O Mayer Selected Research

Insulin Resistance

1/2017	Success and failure of cardiovascular disease prevention in Czech Republic over the past 30 years. Czech part of the EUROASPIRE I-IV surveys.
1/2002	Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy subjects.
3/2000	Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

O Mayer Research Topics

Disease

3	Coronary Disease (Coronary Heart Disease) 01/2017 - 10/2004
3	Insulin Resistance 01/2017 - 03/2000
3	Vascular Diseases (Vascular Disease) 08/2016 - 04/2003
3	Hypertension (High Blood Pressure) 04/2006 - 07/2001
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 01/2002
2	Stroke (Strokes) 06/2015 - 04/2003
2	Heart Failure 01/2008 - 01/2005
2	Infections 08/2003 - 04/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2003 - 07/2001
1	Dyslipidemias (Dyslipidemia) 01/2017
1	Hypertriglyceridemic Waist 01/2017
1	Hypertriglyceridemia 08/2016
1	Vascular Calcification 01/2016
1	Sepsis (Septicemia) 04/2011
1	Necrotizing Enterocolitis 04/2011
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2010
1	Venous Thromboembolism 06/2010
1	Lung Neoplasms (Lung Cancer) 06/2010
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 06/2010
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2009
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2009
1	Overweight 04/2006
1	Hyperlipidemias (Hyperlipidemia) 10/2004
1	Pulmonary Embolism 08/2003
1	Embolism (Embolus) 08/2003
1	Renal Insufficiency (Renal Failure) 08/2003
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2003
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2003
1	Myocardial Infarction 04/2003
1	Atherosclerosis 10/2001
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 10/2001
1	Hyperlipoproteinemias 03/2001

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 03/2000
4	LipidsIBA 01/2017 - 07/2001
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2009 - 07/2001
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 10/2001
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2008 - 01/2005
2	pro-brain natriuretic peptide (1-76)IBA 01/2008 - 01/2005
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2008 - 01/2005
2	HomocysteineIBA 04/2006 - 01/2002
2	Insulin (Novolin)FDA Link 01/2002 - 03/2000
1	oxidized low density lipoproteinIBA 01/2017
1	Vitamin K FDA Link 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Prothrombin (Factor II)IBA 06/2015
1	LeptinIBA 11/2010
1	Anticardiolipin AntibodiesIBA 06/2010
1	AcidsIBA 06/2010
1	Messenger RNA (mRNA)IBA 06/2010
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 06/2010
1	Antiphospholipid AntibodiesIBA 06/2010
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2009
1	Endothelin-1 (Endothelin 1)IBA 01/2005
1	AnticoagulantsIBA 08/2003
1	fibrin fragment D (D-dimer)IBA 08/2003
1	Fumigant 93 (D-D)IBA 08/2003
1	Immunoglobulin A (IgA)IBA 04/2003
1	Triglycerides (Triacylglycerol)IBA 09/2002
1	LDL CholesterolIBA 09/2002
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2002
1	PharmavitIBA 03/2001

Therapy/Procedure

3	Therapeutics 01/2017 - 04/2003
2	Secondary Prevention 08/2016 - 10/2004
1	Parenteral Nutrition 04/2011
1	Renal Dialysis (Hemodialysis) 04/2003